ATE163048T1 - Hybrides protein c - Google Patents

Hybrides protein c

Info

Publication number
ATE163048T1
ATE163048T1 AT91901991T AT91901991T ATE163048T1 AT E163048 T1 ATE163048 T1 AT E163048T1 AT 91901991 T AT91901991 T AT 91901991T AT 91901991 T AT91901991 T AT 91901991T AT E163048 T1 ATE163048 T1 AT E163048T1
Authority
AT
Austria
Prior art keywords
human
protein
modified
molecules
heavy chain
Prior art date
Application number
AT91901991T
Other languages
English (en)
Inventor
Donald C Foster
Richard D Holly
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE163048T1 publication Critical patent/ATE163048T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AT91901991T 1989-12-29 1990-12-28 Hybrides protein c ATE163048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45885689A 1989-12-29 1989-12-29
US51537890A 1990-04-27 1990-04-27

Publications (1)

Publication Number Publication Date
ATE163048T1 true ATE163048T1 (de) 1998-02-15

Family

ID=27039137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91901991T ATE163048T1 (de) 1989-12-29 1990-12-28 Hybrides protein c

Country Status (11)

Country Link
US (1) US5766921A (de)
EP (1) EP0506821B1 (de)
JP (1) JP3270462B2 (de)
AT (1) ATE163048T1 (de)
AU (1) AU7168591A (de)
CA (1) CA2071630C (de)
DE (1) DE69032029T2 (de)
DK (1) DK0506821T3 (de)
ES (1) ES2113878T3 (de)
GR (1) GR3026414T3 (de)
WO (1) WO1991009960A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
SV1999000067A (es) * 1998-06-01 2000-07-06 Lilly Co Eli Proteina humana c polipeptida ref. x-12279
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
EP1090130A1 (de) * 1999-04-30 2001-04-11 Eli Lilly And Company Protein c derivaten
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
CA2399267A1 (en) 2000-02-02 2001-08-09 Eli Lilly And Company Protein c derivatives
CA2400187A1 (en) 2000-02-11 2001-08-16 Eli Lilly And Company Protein c derivatives
US6933367B2 (en) 2000-10-18 2005-08-23 Maxygen Aps Protein C or activated protein C-like molecules
AU2002210388B2 (en) * 2000-10-18 2006-11-23 Perseid Therapeutics Llc Protein C or activated protein C like molecules
WO2003007686A2 (en) * 2001-07-19 2003-01-30 Dmi Biosciences, Inc. Use of copper chelators to inhibit the inactivation of protein c
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
WO2006014839A2 (en) * 2004-07-23 2006-02-09 The University Of Rochester Activated protein c inhibits undesirable effects of plasminogen activator in the brain
EP1781782B1 (de) * 2004-08-17 2010-05-26 CSL Behring GmbH Modifizierte vitamin-k-abhängige polypeptide
EP2242875A4 (de) * 2008-01-15 2012-04-04 Univ British Columbia Protein-c-rs2069915 als reaktionsprädiktor für überlebensrate und verabreichung einer aktivierten protein-c- oder protein-c-ähnlichen verbindung
WO2012068519A2 (en) 2010-11-19 2012-05-24 Sirius Genomics Inc. Markers associated with response to activated protein c administration, and uses thereof
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin
US4902614A (en) * 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
DE3688900T3 (de) * 1985-06-27 1998-06-10 Zymogenetics Inc Expression von Protein C.
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
EP0245949B1 (de) * 1986-04-09 1997-10-29 Eli Lilly And Company Verfahren zur Anwendung von den BK-Virus-Verstärker enthaltenden eukaryotischen Expressionsvektoren
DK323587D0 (da) * 1987-06-25 1987-06-25 Novo Industri As Protein
WO1989012685A1 (en) * 1987-05-18 1989-12-28 Integrated Genetics, Inc. Improved protein c molecules and method for making and activating same
JP2799316B2 (ja) * 1987-06-12 1998-09-17 ヘキスト・マリオン・ルセル株式会社 雑種ヒトプロテインｃおよびその遺伝子工学的製法
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
JP2643968B2 (ja) * 1988-02-03 1997-08-25 サントリー株式会社 Ｋｅｘ２エンドプロテアーゼ及びその製造方法
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
JPH0246296A (ja) * 1988-08-09 1990-02-15 Hoechst Japan Ltd 雑種プロテインｃ及びその製造方法
FI85342C (fi) * 1989-02-03 1992-04-10 Tampella Oy Ab Foerfarande och anordning foer befuktning av partiklar i gasstroemningen.
EP1029921B1 (de) * 1989-03-06 2002-10-23 The Board of Regents of The University of Texas System Serpin-resistenter T-PA; Mutanten; Gene
JP3045307B2 (ja) * 1989-08-11 2000-05-29 ザイモジェネティクス，インコーポレイティド 活性化プロテインｃを生成するための細胞培養法

Also Published As

Publication number Publication date
AU7168591A (en) 1991-07-24
CA2071630C (en) 2000-02-22
US5766921A (en) 1998-06-16
EP0506821A4 (en) 1992-11-04
JP3270462B2 (ja) 2002-04-02
CA2071630A1 (en) 1991-06-30
EP0506821A1 (de) 1992-10-07
JPH06502986A (ja) 1994-04-07
ES2113878T3 (es) 1998-05-16
DE69032029T2 (de) 1998-08-20
DE69032029D1 (de) 1998-03-12
WO1991009960A1 (en) 1991-07-11
EP0506821B1 (de) 1998-02-04
DK0506821T3 (da) 1998-03-30
GR3026414T3 (en) 1998-06-30

Similar Documents

Publication Publication Date Title
ATE163048T1 (de) Hybrides protein c
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
DE3484616D1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
FI905956A (fi) Foerfarande foer producering av ett biologiskt aktivt protein.
DE69430253T2 (de) Komplement verwandte proteine und kohlenhydrate enthaltende zusammensetzungen und methoden zur herstellung und verwendung dieser zusammensetzungen
DE69128362D1 (de) Zusammensetzungen und verfahren zur identifizierung von molekülen mit biologischer wirksamkeit
EA199900464A1 (ru) Способы и композиции для стимуляции роста невритов
DE69034261D1 (de) Antikörper gegen VLA-4
MX2021000401A (es) Nuevas proteinas de fusion especificas para cd137 y pd-l1.
DE60102147D1 (de) Anti-gefrier proteine, deren herstellung und verwendung
DE69510356D1 (de) Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
DE60215649D1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
DE69433243D1 (de) Verwendunf von ApoE zum Binden von TAU und MAP2c Proteinen und zur Behandlung von Alzheimer's Krankheit
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
HU895788D0 (en) Process for producing peptides and medical products containing them
ATE251640T1 (de) Neues chondrozytprotein
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
DE69113049T2 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
ATE452139T1 (de) Peptid-köder zur herstellung von medikamenten, die für die prävention oder behandlung von autoimmunerkrankungen bzw. problemen, die mit dem auftreten von gegen exogene proteine gerichteten antikörpern in zusammenhang stehen, bestimmt sind
DE3485773D1 (de) Aus kultivierten mesenchymzellen extrahierte makromolekuele zur behandlung von degenerationskrankheiten.
BG60657B2 (en) Human recombinant interleukin-2 muteins
DE60326157D1 (de) Verfahren zur identifizierung von modulatoren der glucoseaufnahme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee